Regional Analysis

Hemostasis and Tissue Sealing Agents Market Regional Insights

In 2023, North America dominated the hemostasis and tissue sealing agents market in terms of revenue share, followed by Europe and Asia Pacific. North America has dominated the global hemostasis and tissue sealing agents market over the past decade. The strong presence of leading medical device companies in the U.S., such as Ethicon (Johnson & Johnson), Baxter, Medtronic, and others, has established the region as a pioneer in developing innovative hemostatic and tissue sealing products. As per U.S. International Trade Commission data published in January 2022, medical devices accounted for over 45% of U.S. exports in 2021, indicating the large export potential of hemostasis products from the region.

Europe is also a significant market for hemostasis and tissue sealing agents market, owing to the high usage of topical hemostats frequently used in surgery to control minor bleeding and seal tissues. Their usage has grown significantly in Europe in recent years as minimally invasive procedures have become more widely adopted.

The Asia Pacific region has emerged as the fastest-growing market for hemostasis and tissue sealing agents over the recent past. According to statistics published by Asia Plastic Surgery in 2020, 22,642 surgical procedures were performed in Japan in 2020, indicating a large patient population requiring hemostasis management in postoperative care. Countries like China and India have also seen tremendous growth in their healthcare sectors, fueled by improving access, rising medical tourism, and increasing investments from both public and private players.

Figure 1. Global Hemostasis And Tissue Sealing Agents Market Share (%), By Region, 2023